[go: up one dir, main page]

Montagner et al., 2011 - Google Patents

Synthesis, characterization and cytotoxic activity of palladium (II) dithiocarbamate complexes with α, ω-diamines

Montagner et al., 2011

View PDF
Document ID
5454624461797103062
Author
Montagner D
Marzano C
Gandin V
Publication year
Publication venue
Inorganica Chimica Acta

External Links

Snippet

The polymeric [PdCl (dithiocarbamate)] n complexes, in which the ligand ion is dimethyldithiocarbamate (DMDT), pyrrolidine dithiocarbamate (PyDT,(CH2) 4NCS2−) and sarcosine ethyl ester dithiocarbamate (ESDT, EtO2CCH2N (CH3) CS2−), have been reacted …
Continue reading at mural.maynoothuniversity.ie (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/002—Osmium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
    • A61K47/48061—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a heterocyclic compound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/04—Nickel compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic System
    • C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic System compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals

Similar Documents

Publication Publication Date Title
Marzano et al. Synthesis of a new platinum (II) complex: anticancer activity and nephrotoxicity in vitro
Lam et al. Development of ruthenium (II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus
Selvakumaran et al. Synthesis, structural characterization and cytotoxicity of nickel (II) complexes containing 3, 3-dialkyl/aryl-1-benzoylthiourea ligands
Kraker et al. Anticancer activity in murine and human tumor cell lines of bis (platinum) complexes incorporating straight-chain aliphatic diamine linker groups
Oladipo et al. Ag (I) symmetrical N, N′-diarylformamidine dithiocarbamate PPh3 complexes: Synthesis, structural characterization, quantum chemical calculations and in vitro biological studies
Montagner et al. Synthesis, characterization and cytotoxic activity of palladium (II) dithiocarbamate complexes with α, ω-diamines
Williams et al. (C^ N pz^ C) Au III complexes of acyclic carbene ligands: synthesis and anticancer properties
JP7304128B2 (en) Texaphyrin-platinum(IV) conjugates and compositions for use in overcoming platinum resistance
Talancon et al. Diastereomerically pure platinum (II) complexes as antitumoral agents.: The influence of the mode of binding {(N),(N, O)− or (C, N)}− of (1S, 2R)[(η5-C5H5) Fe {(η5-C5H4) CHNCH (Me) CH (OH) C6H5}] and the arrangement of the auxiliary ligands
Mansouri-Torshizi et al. DNA-binding studies of some potential antitumor 2, 2’–bipyridine Pt (II)/Pd (II) complexes of piperidinedithiocarbamate. Their synthesis, spectroscopy and cytotoxicity
Reji et al. Synthesis, characterization, cytotoxicity, DNA cleavage and antimicrobial activity of homodinuclear lanthanide complexes of phenylthioacetic acid
Mansouri-Torshizi et al. Diimine platinum (II) and palladium (II) complexes of dithiocarbamate derivative as potential antitumor agents: synthesis, characterization, cytotoxicity, and detail DNA-binding studies
Yıldız et al. The comparative study of the DNA binding and biological activities of the quaternized dicnq as a dicationic form and its platinum (II) heteroleptic cationic complex
Wang et al. Design and synthesis of a new series of low toxic naphthalimide platinum (IV) antitumor complexes with dual DNA damage mechanism
Williams et al. Acridine-decorated cyclometallated gold (iii) complexes: synthesis and anti-tumour investigations
Kalaiarasi et al. Biological evaluation of new organoruthenium (II) metallates containing 3-acetyl-8-methoxy-2H-chromen-2-one appended CNS donor Schiff bases
Kashar et al. Spectroscopic inspection, DFT analysis, biological evaluation and molecular docking studies of new 2-(phenylamino) acetohydrazide hydrazone based-transition metal complexes
Dorairaj et al. Effect of new Pd (II)-aroylthiourea complex on pancreatic cancer cells
Fatahian-Nezhad et al. Synthesis, characterization, structural studies, DNA interaction, and cytotoxic studies of palladium (II) mixed-ligand complexes containing 2, 2′-bipyridine, 5, 6-dimethyl-1, 10-phenanthroline and tetrazole-5-thiol ligands
Štarha et al. Platinum (II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines
Intini et al. Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties
Zhao et al. Synthesis, characterization and biological activity of complexes of lanthanum (III) with 2-(1′-phenyl-2′-carboxyl-3′-aza-n-butyl)-1, 10-phenanthroline and 2-(1′-p-phenol-2′-carboxyl-3′-aza-n-butyl)-1, 10-phenanthroline
Zhao et al. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt (NH3) 2Cl]+ units bridged by 4, 4′-dipyridyl selenides or sulfides
Sandlin et al. Effects of amine ligand bulk and hydrogen bonding on the rate of reaction of platinum (II) diamine complexes with key nucleotide and amino acid residues
Liu et al. Synthesis and anticancer activity of [2-hydroxy-1, 3-diaminopropane-κ2N, N′] platinum (II) complexes